• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE,INC NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE,INC NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-300M-K
Device Problem Low impedance (2285)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/17/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial implant was performed on (b)(6) 2017.The system included the rns neurostimulator, sn (b)(4); two depth leads dl-344-10.Port 1, sn (b)(4), left mesial temporal.Port 2, sn (b)(4), right mesial temporal.
 
Event Description
On (b)(6) 2017, neuropace field clinical engineers noted abnormal impedances on the right depth lead connected to the neurostimulator on port 2.The interrogation report on pdms displayed insufficient charge and low impedances.The site originally assumed that this was a result of the distal portion of the lead being placed in csf of a large ventricle.However the treating clinician ordered a head x-ray to determine if the lead was properly seated within port 2 of the neurostimulator.The x-rays were reviewed by both the treating clinician and neuropace.While no clinical abnormalities were noted, neuropace did note that there was possible evidence indicative of potential misalignment that would be consistent with the abnormal impedances measured on that lead.No further action was taken by the treating site at that time.On (b)(6) 2017, the patient underwent an exploratory surgery to establish the cause for the abnormal impedance measurements on the right depth lead.Upon opening and exposing the lead and connector cover, the surgeon established that all contacts on the lead were not fully seated in the connector cover.A new connector cover was attached to the neurostimulator and the leads were re-connected.Impedances and real-time ecogs were taken.Impedance measurements were all within the normal range and the ecog signal looked electrographic in nature.A second impedance measurement and real-time ecog were taken after the wound was closed and all measurements remained in good standing.A review of the neurostimulator data in pdms identified that no impedance measurements were performed at the time of the initial implant; therefore there were no baseline impedances to compare against.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE,INC
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE,INC
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave
mountain view, CA 94043
6502372788
MDR Report Key7113789
MDR Text Key94736752
Report Number3004426659-2017-00059
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005120
UDI-Public010085554700512017170703
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial
Report Date 12/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberRNS-300M-K
Device Catalogue Number1007603
Device Lot Number22950-1-1-1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/17/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age38 YR
-
-